Beyond IQ: executive function deficits and their relation to functional, clinical, and neuroimaging outcomes in 3q29 deletion syndrome.

Rebecca M Pollak, Esra Sefik, Katrina Aberizk, Kuaikuai Duan, Roberto Espana, Ryan M Guest, Adam E Goldman-Yassen, Katrina Goines, Derek M Novacek, Celine A Saulnier, Cheryl Klaiman, Stormi Pulver, Joseph F Cubells, T Lindsey Burrell, Sarah Shultz, Elaine F Walker, Melissa M Murphy, Jennifer G Mulle
Author Information
  1. Rebecca M Pollak: Center for Advanced Biotechnology and Medicine, Robert Wood Johnson Medical School, Rutgers University, Piscataway, NJ, USA. ORCID
  2. Esra Sefik: Princeton Neuroscience Institute, Princeton University, Princeton, NJ, USA.
  3. Katrina Aberizk: Department of Psychology, Emory University, Atlanta, GA, USA.
  4. Kuaikuai Duan: Marcus Autism Center, Children's Healthcare of Atlanta & Emory University School of Medicine, Atlanta, GA, USA.
  5. Roberto Espana: Department of Psychology, Emory University, Atlanta, GA, USA.
  6. Ryan M Guest: Department of Psychology, Emory University, Atlanta, GA, USA.
  7. Adam E Goldman-Yassen: Department of Radiology and Imaging Sciences, Emory University School of Medicine, Atlanta, GA, USA.
  8. Katrina Goines: Department of Psychology, Emory University, Atlanta, GA, USA.
  9. Derek M Novacek: Desert Pacific Mental Illness Research, Education, and Clinical Center, VA Greater Los Angeles Healthcare System, Los Angeles, CA, USA.
  10. Celine A Saulnier: Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.
  11. Cheryl Klaiman: Marcus Autism Center, Children's Healthcare of Atlanta & Emory University School of Medicine, Atlanta, GA, USA.
  12. Stormi Pulver: Marcus Autism Center, Children's Healthcare of Atlanta & Emory University School of Medicine, Atlanta, GA, USA.
  13. Joseph F Cubells: Department of Human Genetics, Emory University School of Medicine, Atlanta, GA, USA.
  14. T Lindsey Burrell: Atlanta Children's Center, Atlanta, GA, USA.
  15. Sarah Shultz: Marcus Autism Center, Children's Healthcare of Atlanta & Emory University School of Medicine, Atlanta, GA, USA.
  16. Elaine F Walker: Department of Psychology, Emory University, Atlanta, GA, USA.
  17. Melissa M Murphy: Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.
  18. Jennifer G Mulle: Center for Advanced Biotechnology and Medicine, Robert Wood Johnson Medical School, Rutgers University, Piscataway, NJ, USA.

Abstract

BACKGROUND: 3q29 deletion syndrome (3q29del) is a rare (~1:30 000) genomic disorder associated with a wide array of neurodevelopmental and psychiatric phenotypes. Prior work by our team identified clinically significant executive function (EF) deficits in 47% of individuals with 3q29del; however, the nuances of EF in this population have not been described.
METHODS: We used the Behavior Rating Inventory of Executive Function (BRIEF) to perform the first in-depth assessment of real-world EF in a cohort of 32 individuals with 3q29del (62.5% male, mean age = 14.5 ± 8.3 years). All participants were also evaluated with gold-standard neuropsychiatric and cognitive assessments. High-resolution structural magnetic resonance imaging was performed on a subset of participants ( = 24).
RESULTS: We found global deficits in EF; individuals with 3q29del scored higher than the population mean on the BRIEF global executive composite (GEC) and all subscales. In total, 81.3% of study subjects ( = 26) scored in the clinical range on at least one BRIEF subscale. BRIEF GEC scores were higher among 3q29del participants with a diagnosis of attention deficit/hyperactivity disorder (ADHD), and BRIEF GEC scores were associated with schizophrenia spectrum symptoms as measured by the Structured Interview for Psychosis-Risk Syndromes. BRIEF GEC scores were not associated with cognitive ability. The BRIEF-2 ADHD form accurately (sensitivity = 86.7%) classified individuals with 3q29del based on ADHD diagnosis status. BRIEF GEC scores were correlated with cerebellar white matter and subregional cerebellar cortex volumes.
CONCLUSIONS: Together, these data expand our understanding of the phenotypic spectrum of 3q29del and identify EF as a core feature linked to both psychiatric and neuroanatomical features of the syndrome.

Keywords

References

  1. Nat Genet. 2017 Jan;49(1):27-35 [PMID: 27869829]
  2. Semin Clin Neuropsychiatry. 1999 Jan;4(1):24-33 [PMID: 10229790]
  3. Clinics (Sao Paulo). 2011;66 Suppl 1:71-7 [PMID: 21779725]
  4. J Am Acad Child Adolesc Psychiatry. 2007 Nov;46(11):1437-44 [PMID: 18049293]
  5. Schizophr Bull. 2008 Jan;34(1):155-72 [PMID: 17562694]
  6. J Psychiatr Res. 2007 Oct;41(8):645-51 [PMID: 16626741]
  7. Front Psychiatry. 2013 Jun 24;4:35 [PMID: 23805107]
  8. Nat Neurosci. 2013 Jan;16(1):16-24 [PMID: 23201973]
  9. Psychopathology. 2008;41(4):206-13 [PMID: 18408416]
  10. Am J Hum Genet. 2010 Aug 13;87(2):229-36 [PMID: 20691406]
  11. Psychol Med. 2005 Aug;35(8):1097-108 [PMID: 16116936]
  12. Mol Psychiatry. 2014 Jul;19(7):762-73 [PMID: 24776740]
  13. Neurosci Biobehav Rev. 2023 Sep;152:105280 [PMID: 37315660]
  14. J Atten Disord. 2006 Aug;10(1):44-53 [PMID: 16840592]
  15. Schizophr Bull. 2003;29(4):703-15 [PMID: 14989408]
  16. Child Dev. 2010 Nov-Dec;81(6):1641-60 [PMID: 21077853]
  17. Cerebellum. 2012 Jun;11(2):505-25 [PMID: 22068584]
  18. Clin Dysmorphol. 2015 Jul;24(3):89-94 [PMID: 25714563]
  19. Am J Hum Genet. 2005 Jul;77(1):154-60 [PMID: 15918153]
  20. Cortex. 2010 Jul-Aug;46(7):831-44 [PMID: 20152963]
  21. J Autism Dev Disord. 2024 Aug;54(8):3142-3154 [PMID: 37354284]
  22. Mol Psychiatry. 2015 Sep;20(9):1028-9 [PMID: 26055425]
  23. Atten Defic Hyperact Disord. 2018 Dec;10(4):309-316 [PMID: 29663184]
  24. Neurosci Lett. 2019 Jan 1;688:62-75 [PMID: 29997061]
  25. World J Biol Psychiatry. 2009;10(4 Pt 2):442-51 [PMID: 18609418]
  26. J Int Neuropsychol Soc. 2018 Oct;24(9):905-916 [PMID: 30375321]
  27. Child Neuropsychol. 2009 Jan;15(1):53-72 [PMID: 18608232]
  28. Child Dev Perspect. 2012 Dec;6(4):361-366 [PMID: 25419230]
  29. Annu Rev Psychol. 2013;64:135-68 [PMID: 23020641]
  30. Elife. 2018 Aug 13;7: [PMID: 30102151]
  31. Proc Natl Acad Sci U S A. 2010 Feb 23;107(8):3805-10 [PMID: 20133708]
  32. Psychol Sci. 2006 Feb;17(2):172-9 [PMID: 16466426]
  33. Nature. 2014 Jan 16;505(7483):361-6 [PMID: 24352232]
  34. Neuron. 2004 Oct 28;44(3):453-67 [PMID: 15504326]
  35. J Consult Clin Psychol. 2004 Oct;72(5):757-66 [PMID: 15482034]
  36. Am J Med Genet A. 2016 Apr;170A(4):999-1006 [PMID: 26738761]
  37. J Atten Disord. 2020 Jan;24(1):41-51 [PMID: 30296883]
  38. Brain. 1998 Apr;121 ( Pt 4):561-79 [PMID: 9577385]
  39. Cogn Psychol. 2000 Aug;41(1):49-100 [PMID: 10945922]
  40. J Neurodev Disord. 2023 May 13;15(1):15 [PMID: 37173621]
  41. Child Neuropsychol. 2002 Jun;8(2):71-82 [PMID: 12638061]
  42. BMC Psychiatry. 2018 Jun 8;18(1):183 [PMID: 29884173]
  43. Cell Rep. 2018 Aug 21;24(8):2029-2041 [PMID: 30134165]
  44. Cell Signal. 2009 Mar;21(3):384-93 [PMID: 19036346]
  45. J Intellect Disabil Res. 2024 Feb;68(2):113-127 [PMID: 37740553]
  46. Cerebellum. 2007;6(3):184-92 [PMID: 17786814]
  47. Biol Psychiatry. 2008 Jul 15;64(2):81-8 [PMID: 18395701]
  48. Am J Hum Genet. 2009 Feb;84(2):148-61 [PMID: 19166990]
  49. Biol Psychiatry. 2012 Mar 1;71(5):443-50 [PMID: 22153589]
  50. Clin Neuropsychol. 2007 Jul;21(4):569-86 [PMID: 17613979]
  51. J Atten Disord. 2018 Feb;22(4):379-387 [PMID: 25917958]
  52. J Autism Dev Disord. 2024 Jan 12;: [PMID: 38216835]
  53. Neuron. 2015 Sep 23;87(6):1215-1233 [PMID: 26402605]
  54. J Nerv Ment Dis. 2008 May;196(5):384-9 [PMID: 18477880]
  55. Proc Natl Acad Sci U S A. 2005 Oct 11;102(41):14931-6 [PMID: 16192352]
  56. J Intellect Disabil Res. 2023 Mar;67(3):216-227 [PMID: 35297118]
  57. Mol Cytogenet. 2008 Apr 28;1:8 [PMID: 18471269]
  58. Genet Med. 2021 May;23(5):872-880 [PMID: 33564151]
  59. Biol Psychiatry. 2017 Jul 15;82(2):103-110 [PMID: 27773354]
  60. Mol Psychiatry. 2012 Feb;17(2):142-53 [PMID: 22083728]
  61. J Am Acad Child Adolesc Psychiatry. 2005 Feb;44(2):177-86 [PMID: 15689731]
  62. Mol Autism. 2019 Jul 16;10:30 [PMID: 31346402]
  63. Psychol Med. 2023 Mar 29;:1-10 [PMID: 36987693]
  64. Mol Psychiatry. 2024 Nov;29(11):3395-3411 [PMID: 38744992]
  65. Autism Res. 2023 Dec;16(12):2247-2262 [PMID: 37997544]
  66. J Child Psychol Psychiatry. 2014 Apr;55(4):374-83 [PMID: 24256459]
  67. Dev Rev. 2019 Jun;52:42-62 [PMID: 31417205]
  68. Dev Psychobiol. 2000 Mar;36(2):161-74 [PMID: 10689286]
  69. Neuropsychopharmacology. 2010 Jan;35(1):258-77 [PMID: 19693005]
  70. Epilepsy Behav. 2009 Jul;15(3):294-8 [PMID: 19362604]
  71. Arch Clin Neuropsychol. 2000 Jan;15(1):31-6 [PMID: 14590565]
  72. Nature. 2022 Apr;604(7906):509-516 [PMID: 35396579]
  73. Transl Psychiatry. 2021 Jun 15;11(1):357 [PMID: 34131099]

Grants

  1. R01 MH118534/NIMH NIH HHS

Word Cloud

Created with Highcharts 10.0.0BRIEF3q29delEFGECexecutiveindividuals=scores3q29deletionsyndromeassociatedfunctiondeficitsparticipantsADHDdisorderpsychiatricpopulationmeancognitiveglobalscoredhigherclinicaldiagnosisschizophreniaspectrumcerebellarBACKGROUND:rare~1:30000genomicwidearrayneurodevelopmentalphenotypesPriorworkteamidentifiedclinicallysignificant47%howevernuancesdescribedMETHODS:usedBehaviorRatingInventoryExecutiveFunctionperformfirstin-depthassessmentreal-worldcohort32625%maleage145±83yearsalsoevaluatedgold-standardneuropsychiatricassessmentsHigh-resolutionstructuralmagneticresonanceimagingperformedsubset24RESULTS:foundcompositesubscalestotal813%studysubjects26rangeleastonesubscaleamongattentiondeficit/hyperactivitysymptomsmeasuredStructuredInterviewPsychosis-RiskSyndromesabilityBRIEF-2formaccuratelysensitivity867%classifiedbasedstatuscorrelatedwhitemattersubregionalcortexvolumesCONCLUSIONS:TogetherdataexpandunderstandingphenotypicidentifycorefeaturelinkedneuroanatomicalfeaturesBeyondIQ:relationfunctionalneuroimagingoutcomescognitioncopynumbervariant

Similar Articles

Cited By